Insurance expenditures on bipolar disorder: clinical and parity implications.
about
Epidemiological and clinical aspects of bipolar disorders: controversies or a common need to redefine the aims and methodological aspects of surveysRisk of suicidal behavior with antidepressants in bipolar and unipolar disordersEpidemiology and burden of bipolar disorder in Africa: a systematic review of data from Africa.Does the use of an automated tool for self-reporting mood by patients with bipolar disorder bias the collected data?Association between duration of untreated bipolar disorder and clinical outcome: data from a Brazilian sample.Depression diagnoses following the identification of bipolar disorder: costly incongruent diagnoses.Treatment use and costs among privately insured youths with diagnoses of bipolar disorder.Tools to improve differential diagnosis of bipolar disorder in primary care.A Long Time Coming - The Creation of an Evidence Base for Physical Activity Prescription to Improve Health Outcomes in Bipolar DisorderBurden of illness in bipolar depression.Quetiapine: a pharmacoeconomic review of its use in bipolar disorder.Three studies on self-report scales to detect bipolar disorderDiagnosis and treatment of bipolar disorders in adults: a review of the evidence on pharmacologic treatments.Hypomanic Experience in Young Adults Confers Vulnerability to Intrusive Imagery After Experimental Trauma: Relevance for Bipolar Disorder.Patterns of initiation of second generation antipsychotics for bipolar disorder: a month-by-month analysis of provider behavior.Randomized controlled trial of a health plan-level mood disorders psychosocial intervention for solo or small practices.Incurring greater health care costs: risk stratification of employees with bipolar disorderImplementing composite quality metrics for bipolar disorder: towards a more comprehensive approach to quality measurementSexually dimorphic, developmental, and chronobiological behavioral profiles of a mouse mania model.Mental health service use by children with serious emotional and behavioral disturbance: results from the LAMS studyEmerging experimental therapeutics for bipolar disorder: insights from the molecular and cellular actions of current mood stabilizers.Mood disorder symptoms and elevated cardiovascular disease risk in patients with bipolar disorder.Quality of life among bipolar disorder patients misdiagnosed with major depressive disorderPsychological distress and trends in healthcare expenditures and outpatient healthcareChanges in the quality of care for bipolar I disorder during the 1990sPathways to care for patients with bipolar disorder.Primary care and behavioral health practice size: the challenge for health care reform.miR-149 and miR-29c as candidates for bipolar disorder biomarkers.Quality of life among patients with bipolar disorder in primary care versus community mental health settings.Anxiety disorders and bipolar disorder: a review.The increasing frequency of mania and bipolar disorder: causes and potential negative impacts.Aripiprazole: pharmacology and evidence in bipolar disorder.Development of an integrated psychosocial treatment to address the medical burden associated with bipolar disorder.The relationship between antipsychotic medication adherence and patient outcomes among individuals diagnosed with bipolar disorder: a retrospective studyUse of risperidone long-acting injectable in a rural border community clinic in southern californiaRecovery from multiple episodes of bipolar I depression.Quetiapine monotherapy as treatment for anxiety symptoms in patients with bipolar depression: a pooled analysis of results from 2 double-blind, randomized, placebo-controlled studies.Bipolar-I depression outpatient treatment quality and costs in usual care practiceAre adults with bipolar disorder active? Objectively measured physical activity and sedentary behavior using accelerometry.Directions for future patient-centered and comparative effectiveness research for people with serious mental illness in a learning mental health care system
P2860
Q24810440-C690AE78-53B8-499A-9D22-1AD28184AC59Q28245269-5565BBE4-67EB-4B76-AE44-A204CDCB6F86Q30979299-4E442C58-49C5-446E-9C5F-7453B2FAA18CQ31027146-F2C93202-D91E-4BB0-8E89-1F41207CCF1DQ31037971-5FA71235-A05A-4F5B-AC7A-4422C0FD7F08Q33595327-CF0BD2B6-D550-41B4-A9D9-E13549396B35Q33697168-42E723D0-BC04-44DA-9FE7-75EE16911F99Q33985400-3591C9D5-266C-4293-8DEE-F35ACE0652A9Q34035818-A32AB621-6ADA-42C5-A6EF-7800765300B5Q34248110-CF1F762C-9E1F-47FF-9FAD-AA4EAFE8B2FDQ34272859-0D082C62-FB8E-42B0-A7E1-76BCB82D1ACBQ34355474-CBE24CC7-1D14-43AA-91E4-2223364CC4DAQ34459114-F52E358E-0B8F-4DD4-BD4E-045BBE8F4BD2Q34505854-B577AE82-FC5C-4769-9557-163AF4E8412FQ34636572-AC20EF90-A2E9-4931-8384-C457E4637817Q34707121-DBA5EA9A-4F88-41D4-80D3-62C15C7C5AC4Q34795108-845421C0-4DC2-407A-BF00-D81E767AA580Q34905003-6BD44C79-68A6-4209-98F8-9A216E351C96Q34964892-3FA38339-49B9-4A02-8119-BD37E60F12C4Q35625671-1444D5BB-DEEE-4A59-8E99-BBD8E9BF4ED3Q35770186-3103B4BC-DB4A-45D6-BF9C-80730CB996BCQ35836912-EFF6FD0A-911E-4953-A4CA-FD8DEE8533D2Q35875975-B2E6BF41-72D7-4A7B-8081-7850CEA705DEQ35878959-E8459429-29C8-4D95-98C6-1FB2EF73CD68Q36013172-DBCC849F-217C-4738-8337-D19D79078A89Q36130306-87BE38F9-BD27-4EA7-AEA8-9622F15B1AD2Q36240665-385648AE-710A-4F51-8D17-948F054A371BQ36278042-158B14A9-D603-4187-9B08-F5FE3CE3018DQ36561733-5567B827-2530-4C2E-ABB9-3DD0500193F6Q36677643-300EDB26-281E-431B-83B1-6949B8BA4FB1Q36784587-494A4B59-C1EC-484B-AA00-F659F91351D5Q36808054-0B6E0B1F-C430-4789-9993-05AD7724AD77Q36860514-CF268F8A-920D-4178-A6BD-E1B33FD678C9Q37114152-5DD1C08D-7398-4FBF-8A91-58DD84D9D58BQ37225867-D4096EC1-0D4F-4750-8D0E-AF7025FDF7CCQ37334911-25E7C149-BEAD-40D0-B9B4-3AE05385D6F6Q37429709-BA0BA614-E1C0-4FBA-8569-6B92A6EF5398Q37463232-D7072A2D-76CC-4F61-AE0E-E20B7827413BQ37528653-8CD77CE7-D901-4D35-B5B6-E9D7B615CDA1Q38184528-96035FA1-E414-44F3-B225-77BE08D85123
P2860
Insurance expenditures on bipolar disorder: clinical and parity implications.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Insurance expenditures on bipolar disorder: clinical and parity implications.
@ast
Insurance expenditures on bipolar disorder: clinical and parity implications.
@en
type
label
Insurance expenditures on bipolar disorder: clinical and parity implications.
@ast
Insurance expenditures on bipolar disorder: clinical and parity implications.
@en
prefLabel
Insurance expenditures on bipolar disorder: clinical and parity implications.
@ast
Insurance expenditures on bipolar disorder: clinical and parity implications.
@en
P2093
P1476
Insurance expenditures on bipolar disorder: clinical and parity implications.
@en
P2093
David J Kupfer
Pamela B Peele
P304
P356
10.1176/APPI.AJP.160.7.1286
P407
P577
2003-07-01T00:00:00Z